Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,149,310
-
Share change
-
+18,149,310
-
Total reported value
-
$335,952,000
-
Price per share
-
$18.70
-
Number of holders
-
42
-
Value change
-
+$335,952,000
-
Number of buys
-
42
Institutional Holders of HOMOLOGY MEDICINES INC - COM (FIXX) as of Q1 2018
As of 31 Mar 2018,
HOMOLOGY MEDICINES INC - COM (FIXX) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,149,310 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Temasek Holdings (Private) Ltd, FMR LLC, JPMORGAN CHASE & CO, Vivo Capital, LLC, MAVERICK CAPITAL LTD, Rock Springs Capital Management LP, PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, and J. Goldman & Co LP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.